These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38350814)

  • 21. Ocular manifestations of systemic isotretinoin in patients with acne: a systemic review and meta-analysis.
    Elubous KA; Toubasi AA; Elubous A; Alryalat SA; Abous H
    Cutan Ocul Toxicol; 2022 Jun; 41(2):113-122. PubMed ID: 35296199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological and functional assessment of the tear film and meibomian glands in keratoconus.
    Uçakhan ÖÖ; Özcan G
    Eur J Ophthalmol; 2023 Sep; 33(5):1841-1849. PubMed ID: 37203190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines.
    Choi MG; Yeo JH; Kang JW; Chun YS; Lee JK; Kim JC
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):331-338. PubMed ID: 30552510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tear instability in the fellow eye of unilateral nasolacrimal obstruction and resolution with dacryocystorhinostomy.
    Tıskaoğlu NS; Yazıcı A
    Orbit; 2023 Aug; 42(4):404-410. PubMed ID: 36069079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous serum eye drops for dry eye.
    Pan Q; Angelina A; Marrone M; Stark WJ; Akpek EK
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009327. PubMed ID: 28245347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normalized ocular surface temperature models for tear film characteristics and dry eye disease evaluation.
    Su TY; Chang SW
    Ocul Surf; 2021 Jan; 19():74-82. PubMed ID: 32298795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous Serum Eye Drops versus Artificial Tear Drops for Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Wang L; Cao K; Wei Z; Baudouin C; Labbé A; Liang Q
    Ophthalmic Res; 2020; 63(5):443-451. PubMed ID: 31884498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between tear film lipid layer thickness and transepidermal water loss from the ocular area in patients with dry eye disease and in healthy controls.
    Yoon DY; Hee Eun J; Hyon JY
    PLoS One; 2022; 17(7):e0270810. PubMed ID: 35857784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of ocular surface disease index and tear osmolarity as markers of ocular surface dysfunction in video terminal display workers.
    Fenga C; Aragona P; Di Nola C; Spinella R
    Am J Ophthalmol; 2014 Jul; 158(1):41-48.e2. PubMed ID: 24631759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunction.
    Albietz JM; Schmid KL
    Clin Exp Optom; 2018 Jan; 101(1):23-33. PubMed ID: 28585267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of the IL-33/ST2 pathway in dry eye.
    Wang S; Zhang H
    Mol Vis; 2019; 25():583-592. PubMed ID: 31673224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of dry eyes in children with vernal kerato-conjunctivitis using clinical tests and ocular surface analysis.
    Gupta S; Rahman M; Tibrewal S; Gaur A; Ganesh S; Sangwan VS
    Indian J Ophthalmol; 2023 Apr; 71(4):1488-1494. PubMed ID: 37026288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Tear Functions in Patients with Acne Rosacea without Meibomian Gland Dysfunction.
    Ozek D; Evren Kemer Ö; Artüz F
    Ocul Immunol Inflamm; 2019; 27(4):632-635. PubMed ID: 29533687
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of video display terminal use and meibomian gland dysfunction on the ocular surface and tear neuromediators.
    Bilgic AA; Kocabeyoglu S; Dikmetas O; Tan C; Karakaya J; Irkec M
    Int Ophthalmol; 2023 May; 43(5):1537-1544. PubMed ID: 36239837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Tolerability of an Eye Drop Based on 0.6% Povidone-Iodine Nanoemulsion in Dry Eye Patients.
    Oliverio GW; Spinella R; Postorino EI; Inferrera L; Aragona E; Aragona P
    J Ocul Pharmacol Ther; 2021 Mar; 37(2):90-96. PubMed ID: 33370213
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduced tear break-up time in the fellow eye of patients with unilateral primary acquired nasolacrimal duct obstruction.
    Tıskaoğlu NS; Yazıcı A
    Int Ophthalmol; 2023 Mar; 43(3):965-971. PubMed ID: 36053478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study.
    Zhang Q; Zhang H; Qin G; Wu Y; Song Y; Yang L; Yu S; He X; Moore JE; Moutari S; Palme C; Xu L; He W; Pazo EE
    J Ocul Pharmacol Ther; 2022 Mar; 38(2):133-140. PubMed ID: 35049373
    [No Abstract]   [Full Text] [Related]  

  • 39. Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye.
    Wong ABC; Wang MTM; Liu K; Prime ZJ; Danesh-Meyer HV; Craig JP
    Ocul Surf; 2018 Jul; 16(3):289-293. PubMed ID: 29510226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular Surface Changes in Primary Open Angle Glaucoma Patients Treated With Topical Antihypertensive Drugs.
    Castro C; Marta A; Marques JH; Ferreira A; José D; Sousa P; Neves I; Menéres MJ; Barbosa I
    J Glaucoma; 2023 Oct; 32(10):e113-e120. PubMed ID: 37523629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.